Nolan Sean P. bought TSHA
January 12, 2026 · Form 4 insider transaction
Nolan Sean P. bought 648,000 shares of Taysha Gene Therapies, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
648,000
Price
$0.00
Total value
N/A
InsiderNolan Sean P.
RoleOfficer, Director
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 12, 2026
Filing dateJanuary 14, 2026
Shares owned after648,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the total number of shares underlying the option shall vest and become exercisable on January 12, 2027 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.